Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis

Area of Science:

• Genomics
• Bioinformatics
• Oncology

Background:

• Ovarian cancer remains a leading cause of cancer-related mortality.
• Understanding the molecular mechanisms underlying ovarian cancer is crucial for developing effective treatments.

Purpose of the Study:

• To systematically analyze gene expression data to elucidate the mechanisms of ovarian cancer.
• To identify key genes, pathways, and regulatory networks involved in ovarian cancer development.

Main Methods:

• Downloaded and analyzed gene expression data from the Gene Expression Omnibus (GEO) database (GSE14407).
• Identified differentially expressed genes (DEGs) and performed Gene Ontology (GO) and pathway enrichment analyses using DAVID.
• Constructed protein-protein interaction (PPI) and co-expression networks using Cytoscape.

Main Results:

• Identified 1,442 differentially expressed genes in ovarian cancer.
• DEGs were primarily associated with cell cycle, transcription regulation, and cellular protein metabolism.
• Key pathways included the p53 signaling pathway and amino sugar/nucleotide sugar metabolism. Significant nodes in the PPI network included ASPM, AURKA, CCNA2, CCNB1, and CDK1. Aryl hydrocarbon receptor nuclear translocator (ARNT) was identified as a significant transcription factor.

Conclusions:

• The identified genes and pathways represent potential therapeutic targets for ovarian cancer.
• This study provides a comprehensive overview of molecular mechanisms in ovarian cancer, aiding future research and treatment strategies.